Request Demo
Last update 08 May 2025
Monoammonium Glycyrrhizinate/Glycine/Cysteine Hydrochloride
Last update 08 May 2025
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms Monoammonium Glycyrrhizinate/Glycine/L-Cysteine, Monoammonium Glycyrrhizinate/Glycine/L-Cysteine Hydrochloride Hydrate, グリチルリチン酸一アンモニウム/グリシン/L－システイン + [18] |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date Japan (01 Feb 1959), |
Regulation- |
Login to view timeline
Structure/Sequence
Molecular FormulaC42H65NO16 |
InChIKeyILRKKHJEINIICQ-OOFFSTKBSA-N |
CAS Registry53956-04-0 |
View All Structures (3)
Related
1
Clinical Trials associated with Monoammonium Glycyrrhizinate/Glycine/Cysteine HydrochlorideJPRN-UMIN000014234
Post Marketing Study of Stronger Neo Minophagen C for Elderly Patients of Chronic Hepatitis C -Prospective Study- - Post Marketing Study of Stronger Neo Minophagen C for Elderly Patients of Chronic Hepatitis C
100 Clinical Results associated with Monoammonium Glycyrrhizinate/Glycine/Cysteine Hydrochloride
Login to view more data
100 Translational Medicine associated with Monoammonium Glycyrrhizinate/Glycine/Cysteine Hydrochloride
Login to view more data
100 Patents (Medical) associated with Monoammonium Glycyrrhizinate/Glycine/Cysteine Hydrochloride
Login to view more data
1
Literatures (Medical) associated with Monoammonium Glycyrrhizinate/Glycine/Cysteine Hydrochloride01 Jun 1965Jibi inkoka Otolaryngology
[The use of Neo-Minophagen-strong in the treatment of tinnitus with conduction deafness].
Article
Author: Toriyama, Y
100 Deals associated with Monoammonium Glycyrrhizinate/Glycine/Cysteine Hydrochloride
Login to view more data
R&D Status
10 top approved records. to view more data
Login
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Chronic liver disease | Japan | 31 Jan 2001 | |
| Hepatitis, Chronic | Japan | 31 Jan 2001 | |
| Staphylococcal Infections | Japan | 08 Jul 1994 | |
| Liver Diseases | Japan | 16 Sep 1988 | |
| Dermatitis | Japan | 10 Jul 1962 | |
| Drug Eruptions | Japan | 10 Jul 1962 | |
| Papular Urticaria | Japan | 10 Jul 1962 | |
| Stomatitis | Japan | 10 Jul 1962 | |
| Eczema | Japan | 01 Feb 1959 | |
| Hepatic Insufficiency | Japan | 01 Feb 1959 | |
| Oral Ulcer | Japan | 01 Feb 1959 | |
| Pruritus | Japan | 01 Feb 1959 | |
| Urticaria | Japan | 01 Feb 1959 | |
| Hepatitis | China | - | - |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free